Financial Comparison: Sanofi (SNY) & Its Rivals


Sanofi is one of 116 public companies in the "Pharmaceuticals" industry, but how does it weigh in compared to its peers? We will compare Sanofi to similar businesses based on the strength of its valuation, dividends, risk, analyst recommendations, earnings, profitability and institutional ownership. Sanofi has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500.



from Biotech News